At a glance
- Originator Nonindustrial source
- Class Antipsychotics; Butyrophenones; Small molecules
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 17 Nov 1999 New profile
- 17 Nov 1999 Preclinical development for Schizophrenia in Spain (Unknown route)